Latest Executive Changes News

Page 7 of 7
Energy World Corporation has appointed a global investment bank to spearhead funding efforts for its LNG and power projects in the Philippines, while reporting a $3.62 million operating cash outflow and the resignation of a senior executive.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Bastion Minerals Limited has announced the immediate departure of CEO Allister Caird, with directors Gavin Ross and Keith Rutherford stepping in to support a smooth transition during a three-month handover period.
Maxwell Dee
Maxwell Dee
30 Apr 2025
DomaCom Limited reports a transformative quarter with executive changes, new funding facilities, and strategic initiatives including the launch of its Homeowner Equity Fund and exclusive licensing of the Bricklet Homeowner Platform.
Claire Turing
Claire Turing
3 Feb 2025
Range International Limited has appointed Russell Kennett as its new CEO, marking a pivotal step in the company’s growth strategy. The move comes alongside an update to Executive Chairman Richard Jenkins’ remuneration, underscoring leadership continuity.
Victor Sage
Victor Sage
31 Jan 2025
Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.
Maxwell Dee
Maxwell Dee
31 Jan 2025
African Gold Ltd confirms a trading halt as it finalises key exploration results and navigates recent executive changes, signaling pivotal developments for its Didievi Gold Project.
Maxwell Dee
Maxwell Dee
30 Jan 2025
Doctor Care Anywhere delivered positive cash flow and revenue growth at the top of guidance in Q4 2024, while navigating a strategic shift with new leadership appointments and the closure of secondary care pathways.
Ada Torres
Ada Torres
30 Jan 2025
Tower Limited has appointed CFO Paul Johnston as interim CEO following Blair Turnbull's resignation, with Deputy CFO Angus Shelton stepping in as interim CFO pending regulatory approval.
Victor Sage
Victor Sage
23 Jan 2025
Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.
Ada Torres
Ada Torres
23 Jan 2025